Latest in News & Research
Half of Patients With Newly Diagnosed Vitiligo Do Not Receive Treatment
Proportion receiving treatment within 12 months higher with more severe disease
How Does Lesion Visibility Affect Melanoma Prognosis?
Patients with nonvisible lesions more likely to have T3 or T4 tumors, positive lymph nodes, higher-risk stage
Is Autologous Cell Transplant Reliable for Stable Segmental Vitiligo?
Cultivated cells have better results than noncultivated ones; both types pigment 80 percent or more where needed
Autoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19
Risks associated with COVID-19 severity
Risankizumab Treatment Beneficial in Real-World Psoriasis Cohort
High levels of clear and clear/almost clear skin, significant reductions in psoriasis symptoms reported at one year after initiation
Black Race Linked to Worse Survival in Kaposi Sarcoma
Survival benefit seen for Spanish/Hispanic ethnicity, private insurance, residence in areas of high educational attainment
Sexual, Gender Minorities With Chronic Skin Diseases More Likely to Face Barriers to Care
Cost and noncost barriers more likely for sexual and gender-minority patients with chronic inflammatory skin diseases
Children With Eczema More Likely to Have Allergic Contact Dermatitis
Children with atopic dermatitis more likely to have more than one positive patch test result
Vitiligo and Associated Comorbidities: A Review
The pigmentary disorder is linked to a host of autoimmune disorders, ocular and auditory abnormalities, and dermatologic conditions
Does Adding Optical Coherence Tomography Increase Detection of Recurrent, Residual BCC?
Area under curve 0.98 for clinical and dermatoscopic examination combined with OCT and 0.77 for clinical and dermatoscopic examination alone
Itching, Sleep Disturbance Impact QoL in Prurigo Nodularis
All patients with PN reported itch, pain associated with PN, bleeding or scabbing, and having dry skin
Reduced Mortality Risk Seen for Patients With Vitiligo
Lower all-cause and cause-specific mortality seen, including from infectious diseases, oncologic diseases, endocrine diseases
Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children
Greater improvement seen in disease severity by 12 weeks with ciclosporin, but MTX was superior by 60 weeks
Study Looks at Treatment Patterns for Alopecia Areata
47.2 percent received no treatment on day of diagnosis; by one year, 71.8 percent were not receiving treatment
Coronary Microvascular Dysfunction ID'd in 31.5 Percent With Psoriasis
Independent association with CMD seen for higher PASI, longer disease duration, psoriatic arthritis, hypertension
Combo Treatments Efficacious for Generalized-Type Vitiligo
No difference seen in efficacy for NB-UVB treatment combined with tacrolimus 0.1 percent or calcipotriol/betamethasone dipropionate
Somatosensory Profiles Characterized in Hidradenitis Suppurativa
HS lesions insensitive to innocuous cold and warmth, noxious heat, and light touch compared with healthy pain-free controls
Vitiligo Has Considerable Impact on Mental Health
Vitiligo affects patients' daily lives and well-being; more than half of patients report diagnosed mental health conditions
Fecal Microbiota Profile Differs for Melanoma, Healthy Controls
Differences also seen for microbiomes in those with early- and late-stage melanoma, including higher alpha diversity in early-stage
Alterations in Infant Gut Microbiota Precede Development of Eczema
Similar patterns also observed in C-section-born infants
Psychosocial Impact of Vitiligo
Navigating the emotional and social challenges and enhancing support strategies for patients with vitiligo
Atopic Dermatitis Increases Risk for Inflammatory Bowel Disease
Risk varies by age, atopic dermatitis severity, and inflammatory bowel disease subtype
Important Update
Winter Clinical Hawaii in ON for Maui!
24 of 1292